USA: Treatment Modification Aids Chemo Tolerability in Seniors With Advanced Cancer

Primary treatment modification is associated with improved tolerability of chemotherapeutic regimens among older adults with advanced cancer and aging-related conditions, according to a study published online Feb. 15 in JAMA Network Open.

Mostafa R. Mohamed, M.D., Ph.D., from University of Rochester in New York, and colleagues examined the association between primary treatment modification and treatment tolerability in older adults with advanced cancer who were starting new palliative chemotherapy regimens. The analysis included 609 participants in the Geriatric Assessment Intervention for Reducing Toxicity in Older Patients with Advanced Cancer trial.

Source: Advances and More licensed by HealthDay

https://advancesandmore.com/advances_article.htm?id=OTU3MTAxZDQtM2Y0Ny00ZGFhLThmMWYtOTdlNzBkYzBmM2Vi&client=Nw%3D%3D&section=undefined